• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·US·Technology·DOCU
Held by 2 Gurus
Share

DocuSign, Inc. Stocks

$ 68.57Last Updated 21.09.2026

Issuer Rating

4/7
Performance

Average

Risk

Considerable

Recommendation

Hold

Market Cap

$ 13.19B

$ 68.57
Key Takeaways

Risk factor

Weak & very vulnerable to price shocks

Data is available to registered users only
Data is available to registered users only

Profitability factor

Strong growth

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

In Guru Portfolios

Kenneth Griffin

Portfolio Weight (%)

0.0%

Change

-0.01%

Fund

CITADEL ADVISORS LLC

Steven Cohen

Portfolio Weight (%)

0.0%

Change

-0.14%

Fund

Point72 Asset Management, L.P.

Manager
Fund
Portfolio Weight (%)
Change
Kenneth GriffinCITADEL ADVISORS LLC0.0%-0.01%
Steven CohenPoint72 Asset Management, L.P.0.0%-0.14%

Latest news

05.06.2026 15:37

Morning in New York: market focus on Labor Ministry report and IT sector

02.06.2026 09:00

An investor from The Big Short is holding Adobe in the AI era. Which seven stocks is he avoiding?

25.02.2026 02:05

U.S. stocks are up. Why have fears of a soft-apocalypse abated?

05.12.2025 15:25

New York morning: the Fed's favorite inflation indicator in focus

05.09.2025 14:24

Morning in New York: employment data will determine the market vector

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

DocuSign, Inc. is a global provider of electronic signature software, operating both within the United States and internationally. The company's core offering is an e-signature solution that empowers businesses to digitally prepare, execute, finalize, and manage various agreements. Beyond its foundational e-signature service, DocuSign offers an extensive suite of tools for digital agreement management. This includes Contract Lifecycle Management (CLM) to streamline agreement workflows, and Insights, which leverages artificial intelligence to analyze agreements based on legal concepts and clauses. For Salesforce users, there's Gen, enabling sales teams to quickly generate agreements, and Negotiate, providing functionalities like approvals, document comparisons, and version control. Customers can also utilize Analyzer to comprehend documents before signing, and the advanced CLM+ for AI-driven contract lifecycle management. Further enhancing its platform, DocuSign provides Guided Forms for interactive, step-by-step completion of complex documents; Click for managing standard terms and consents that don't require a traditional signature; and Identify, a feature for verifying signer identity using government-issued IDs. It also supports Standards-Based Signatures involving digital certificates, offers Payments for collecting both signatures and financial transactions, and facilitates notarization remotely through its Remote Online Notary solution, which uses audio-visual technology and identity verification. Monitor provides sophisticated analytics for tracking DocuSign eSignature account activity across web, mobile, and API interfaces. DocuSign also caters to specific industries with specialized cloud offerings. These include Rooms for Real Estate, designed to help brokers and agents digitally manage the entirety of real estate transactions; Rooms for Mortgage, a digital workspace for originating and closing mortgages; FedRAMP, a government-authorized version of DocuSign eSignature for U.S. federal agencies; and life sciences modules that ensure compliance with industry-specific electronic signature regulations. The company distributes its products through a combination of direct sales, partner-assisted channels, and Web-based sales, serving a diverse clientele ranging from large enterprises to commercial businesses and small companies. DocuSign, Inc. was established in 2003 and is headquartered in San Francisco, California.

Company Valuation

Slightly overvalued
3/7

From both historical and forecast perspectives, the stock is slightly overpriced compared to similar stocks. Specifically, the stock is fairly valued on P/E, neutral on E

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Neutral
4/7

The average target price of DOCU is 72.4 and suggests 5.51% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendatio

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

22.09.2026 18:05

RBC has downgraded the ratings for LVMH and Burberry. Why don't analysts have confidence in the luxury sector?

22.09.2026 17:45

The Limits of Rationality: Why the Guru Who Predicted the Dot-Com Crash Doesn't Consider AI a Bubble

22.09.2026 17:32

Armenia could become a global AI hub. What does this mean for Central Asia?

22.09.2026 17:23

Paramount has settled its dispute with prosecutors over the Warner Bros. deal. What's next?

22.09.2026 17:00

Grail shares had their best day in 1.5 years. The regulator may approve its cancer test

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026